meddevicedb.com FDA Device Reference

AUTOSURE VOICE 3 BLOOD GLUCOSE MONITORING SYSTEM AND TEST STRIP

K102481 Class II Special
Decision Date
2011-04-28
Sponsor / Applicant
Apex BioTechnology Corp.

Technical Specification

510(k) Submission ID K102481
Product Code NBW
Medical Specialty / Panel Clinical Chemistry
Regulation Citation 21 CFR 862.1345
Decision Date 2011-04-28
Clearance Pathway Special

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

AUTOSURE VOICE 3 BLOOD GLUCOSE MONITORING SYSTEM AND TEST STRIP received FDA 510(k) clearance under submission number K102481, sponsored by Apex BioTechnology Corp.. The device was reviewed via the Special premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2011-04-28.

Classification & Regulation

This clearance is catalogued under FDA product code NBW and 21 CFR 862.1345, within the Clinical Chemistry review panel as a Class II device.